S&P 500 Retreats as Investors Shift Focus to 2026-Q2
The S&P 500 (Index: SPX) hit a brand new record high of 6,693.75 on Monday, 22 September 2025 before retreating in the following days. By the time the trading week ended on Friday, 26 September 2025, the index sat at 6,643.70, down 0.3% from where it closed the preceding week.
The most significant market-moving news of the week continued to be related to the prospects of the Federal Reserve lowering interest rates further. Only this week, the Fed’s minions hit the media circuit with mixed messages about what additional actions they might take after last week’s quarter point rate cut and left the perception they wanted to take back some of the rate cuts investors had come to expect.
Those mixed messages combined with the week’s data flow to affect investor expectations for what rate cuts might happen and when. The CME Group’s FedWatch Tool projects two more quarter point cuts in 2025, coming on 29 October (2025-Q4) and 10 December (2025-Q4), then pausing until the second quarter of 2026 before resuming with another quarter point reduction on 29 April (2026-Q2). Last week, investors had expected the next rate cut would take place in 2026-Q1.
The latest update of the alternative futures chart captures that shift in the time horizon of investors over the past week. The trajectory of the S&P 500 moved from the projected forecast associated with investors focusing on 2026-Q1 to the lower projected path associated with investors fixing their attention on 2026-Q2.
The shift in investor time horizon represents a new Lévy flight event.
What happens with stock prices next will depend upon the random onset of new information investors will absorb in the next week. Here is our summary of the market-moving headlines investors weighed during the trading week ending on 26 September 2025.
- Monday, 22 September 2025
-
- Signs and portents for the U.S. economy:
- Oil prices dip as Iraq increases exports amid demand concerns
- Trump to impose $100,000 fee per year for H-1B visas, in blow to tech
- US new H-1B visa fee will not apply to existing holders, White House says
- Trump’s New H-1B Visa Regulation Sends Shockwaves Through Big Tech
- Computer Science Grads Face 7.5% Unemployment: AI Job Cuts Crush Coding Dream
- Fed minions sow doubt against more rate cuts:
- Fed’s Bostic sees no further rate cuts this year, WSJ reports
- Fed’s Hammack still focused on inflation, calls for caution in easing policy
- Bigger trouble, stimulus developing in China:
- BOJ minions accused of being little different from JapanGov minions:
- Bigger trouble developing in Eurozone:
- Wall Street closed at record levels ahead of further inflation data
- Tuesday, 23 September 2025
-
- Signs and portents for the U.S. economy:
- Oil gains as restart of Kurdistan oil exports stalls
- US business activity moderates; inflation outlook improves
- Fed minions sending mixed messages:
- Fed’s Powell: Repeats no risk-free path as Fed balances job, inflation risks
- There’s no risk-free policy path when both sides of mandate at risk, Powell says
- Miran defends low-rate view as colleagues caution on further cuts
- Fed’s Bowman: Fed needs to be decisive in fending off job market risks
- Fed’s Bostic says inflation risks still present in US economy
- Fed’s Goolsbee, on CNBC, says Fed has room to cut rates
- Bigger trouble developing in China:
- Bigger trouble developing in Eurozone as biggest economies are dragging growth down:
- Exclusive: German economic institutes revise up 2025 growth forecast to 0.2%, sources say
- Euro zone business activity hits 16-month high but highlights country divergence, PMI shows
- Wall Street breaks winning streak as Powell reiterates message from last week
- Wednesday, 24 September 2025
-
- Signs and portents for the U.S. economy:
- US new home sales jump to more than 3-1/2-year high; economists dismiss rise as a fluke
- Fed minions continue sending mixed messages about future for more rate cuts:
- Fed’s Daly: Further rate cuts will likely be needed
- Fed’s Goolsbee says US jobs market steady, cautions against aggressive rate cuts, FT reports
- Bigger trouble, stimulus developing in China:
- China’s COMAC falls behind on C919 aircraft delivery targets, filings show
- Exclusive: G7 weighs price floors for rare earths to counter China’s dominance, sources say
- BOJ minions seriously thinking about hiking Japan’s interest rates in October:
- U.S. stocks fall as tech sector struggles, rate-cut uncertainties rattle markets
- Thursday, 25 September 2025
-
- Signs and portents for the U.S. economy:
- US goods trade deficit contracts sharply in August
- US, Chinese officials to meet at Treasury for technical talks on trade, source says
- US implements EU trade deal, 15% autos tariffs retroactive to Aug 1
- Oil pulls back from seven-week high
- US weekly jobless claims reverse prior surge, labor market still softening
- US existing home sales dip in August
- Fed minions claim they have US interest rates right where they want them, but may want to cut them more, thinking about redoing regulations:
- Fed’s Daly: ‘A little bit more’ rate cutting likely needed ‘over time’
- Fed’s Miran presses case for fast rate cuts, but other policymakers push back
- Fed’s Bowman says regulators to unveil Basel capital rule redo by early 2026
- Fed’s Lisa Cook urges US Supreme Court to reject Trump’s bid to fire her
- Bigger trade deal developing in China:
- Wall Street ended in the red after jobless claims fell and Q2 GDP was revised higher
- Friday, 26 September 2025
-
- Signs and portents for the U.S. economy:
- Oil gains on Ukraine drone attacks cutting Russian supply
- Fed minions keep sending mixed messages:
- Fed’s Bowman says decisive rate cuts needed to offset labor market risks
- Fed’s Barkin: Risks to both inflation, jobs, may be limited
- Trump urges Supreme Court in new filing to allow his firing of Fed’s Lisa Cook
- Bigger trouble, stimulus developing in China:
- EU plans 25% to 50% tariffs on Chinese steel, related products, Handelsblatt reports
- Trump slaps steep US tariffs on drugs, heavy trucks and furniture
- China is confident in sustaining economic growth, premier says
- BOJ minions expected to hike Japan’s interest rates:
- Wall Street ended higher after PCE index data arrived in line with estimates
The Atlanta Fed’s GDPNow tool projection of real GDP growth in the U.S. during the current quarter of 2025-Q3 jumped to +3.9% after last week’s forecast of +3.3% annualized growth.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon with a Wall Street bull wearing a suit who is pulling a wagon filled with boxes that say EXPECTED RATE CUTS with Federal Reserve officials sneakily trying to take some boxes away”.
Source: https://politicalcalculations.blogspot.com/2025/09/s-500-retreats-as-investors-shift-focus.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
